JENNIFER SHERWOOD: Open Payments
NPI 1710429394 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$118 in 6 payments from 5 companies in 2025. Trend: 2023 $93 · 2024 $18 · 2025 $118
Food & beverage: $118
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $34 |
| Neurocrine BioSciences, Inc. | 1 | $32 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: VRAYLAR, INGREZZA, Qelbree, REXULTI, TRINTELLIX.
Industry payments across MD — which companies pay providers there.
